je.st
news
GSK sees drop in earnings after asset swap with Novartis
2015-07-29 15:23:08| Biotech - Topix.net
Britain-based drugmaker GlaxoSmithKline has reported a drop in earnings in the first full quarter since its deal to swap some assets with Swiss rival Novartis. Second-quarter net income fell to 149 million pounds from 654 million pounds a year earlier.
Tags: with
drop
asset
sees
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||